MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

278.17 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
42 43 Next >
News headline image
Over 100,000 Maryland Residents to Lose Medicare Advantage Plans at End of 2025
Via AB Newswire
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices. 
Via Benzinga
News headline image
2 S&P 500 Stocks to Research Further and 1 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Where Cigna Group Stands With Analysts ↗
 
Via Benzinga
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened ↗
Via Stocktwits
News headline image
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? ↗
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
News headline image
AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group
From AM Best
Via Business Wire
News headline image
3 Things Every Older Adult Should Do for Their Health This Fall
Via StatePoint Media
Harmony Grove Recovery Now Accepts Most Major Health Insurances for Addiction Treatment in San Diego
Via AB Newswire
News headline image
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers ↗
Cigna's Evernorth invests $3.5 billion in Shields Health Solutions as Sycamore acquires the firm, while BofA highlights Cigna's strong growth outlook. 
Via Benzinga
News headline image
2 Reasons to Watch ABT and 1 to Stay Cautious
Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Market's Great Divide: AI Fuels Tech Surge, While Healthcare and Energy Grapple with Headwinds
The current financial market is witnessing a stark divergence in sector performance, painting a complex picture for investors and the broader economy. While the technology sector, particularly its... 
Via MarketMinute
Topics Artificial Intelligence Climate Change ETFs
News headline image
Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy — Here's Where He's Investing Instead ↗
A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of his preferred investments. 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Looking At Cigna Group's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Cigna Group Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) ↗
 
Via Benzinga
News headline image
Why I Bought the Dip in UnitedHealth Group ↗
This top health insurer scans as a downright bargain at current levels. 
Via The Motley Fool
News headline image
UnitedHealth Stock Gets Fresh Fuel From Dividend Nod — Now Retail Traders Are Whispering About Warren Buffett Taking Stake ↗
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares. 
Via Stocktwits
News headline image
CI Q2 Deep Dive: Product Innovation and Margins Tested Amid Industry Pressures
Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per... 
Via StockStory
News headline image
5 Insightful Analyst Questions From Cigna’s Q2 Earnings Call
Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite revenue and adjusted earnings per share both coming in ahead of Wall Street... 
Via StockStory
Topics Earnings
News headline image
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Pacific Prime Releases Guide to Getting a Senior Citizen ID (OSCA ID) in the Philippines
Manila () August 3, 2025 -- New Resource Helps Retirees and Expats Access Benefits and Healthcare Savings 
Via Prodigy
News headline image
Pacific Prime Reveals Top International Health Insurance Companies
Manila () August 3, 2025 -- Pacific Prime has released its much-anticipated roundup of the Top 10 International Health Insurance 
Via Prodigy
News headline image
Cigna (CI) Q2 Revenue Jumps 11% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
What 11 Analyst Ratings Have To Say About Cigna Group ↗
 
Via Benzinga
News headline image
5 Dividend Stocks With Solid Returns And More Growth Ahead ↗
 
Via Benzinga
News headline image
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation. 
Via Benzinga
News headline image
Trump Reportedly Taps Wall Street Banks To Explore Fannie, Freddie Public Offering Strategy — Retail Eyes Fresh Highs ↗
According to a Bloomberg News report, Trump already met JPMorgan Chase & Co. CEO Jamie Dimon last week at the White House, followed by talks with Goldman Sachs CEO David Solomon on Thursday. 
Via Stocktwits
Topics Government
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story